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PreviewsmRNAs is a major cis element for cell
cycle regulation in mammalian cells (Mar-
zluff et al., 2008). In addition to regulation
of histone gene transcription, formation of
the 30 end of histone mRNA is regulated,
and processing is inhibited at the end of
S phase. At the end of S phase, the half-
life of histone mRNA is also greatly
reduced, rapidly shutting down histone
protein synthesis. A cell cycle-regulated
factor necessary for histone pre-mRNA
processing, the stem-loop-binding protein
(SLBP) has an expression pattern similar
to Ams2 in S. pombe, being expressed
only in S phase cells. Like Ams1, SLBP
is degraded at the end of S phase as
a result of phosphorylation, in this case
by cyclin A/Cdk1 which is active at
the end of S phase (Koseoglu et al.,
2008). Inappropriate synthesis of the
replication-dependent histone proteins
outside of S phase likely also causes pro-
blems with chromatin structure in meta-
zoans. In Drosophila, blocking histone
pre-mRNA processing by mutations in
SLBP results in production of polyadeny-
lated histone mRNAs, which are not
degraded rapidly when DNA replication
is inhibited. These mutations exhibit336 Developmental Cell 18, March 16, 2010 ªgenetic instability as well as affecting
heterochromatin formation and cell prolif-
eration (Salzler et al., 2009), consistent
with production of histone protein in
G2 phase disrupting normal chromatin
structure.
These studies point out the importance
of producing the right amount of histones
at the correct time, and this paper clearly
demonstrates the defect in chromatin
structure caused by overexpression of
histones in G2 phase. Given the critical
role of histone variants in epigenetic regu-
lation of chromatin structure, it is likely
also critical to properly balance the syn-
thesis of canonical histones and histone
variants in S phase, and to avoid produc-
tion of histones in G1 phase. There are
hints of sophisticated regulatory mecha-
nisms in Drosophila that act to balance
the production of canonical histones and
variant histones. Knockdown of variant
histone H2av or mutants lacking the
H2av gene, have defects in the biosyn-
thesis of the canonical histones, suggest-
ing there is a mechanism to maintain
proper balance of synthesis of the two
types of histone protein during S phase
(Marzluff et al., 2008).2010 Elsevier Inc.REFERENCES
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Pre-mRNA splicing, once thought to be a strictly posttranscriptional event in gene expression, is subject to
a multitiered network of regulation. Luco et al. now report in Science that this regulation seems to begin with
chromatin modifications, suggesting that the histone code may be a prequel to the splicing code.Intervening sequences (or introns) in most
eukaryotic genes must be removed to
produce mature mRNA during gene
expression. Pre-mRNA is often alterna-
tively spliced to give rise to mRNA
isoforms that, in many cases, encode
functionally distinct protein products.
Although splicing can take place in cell-
free extracts, independent of transcrip-tion, mounting evidence suggests that
the process is largely cotranscriptional,
and thus subjected to influence by the
transcription process, particularly tran-
scription elongation. In a study recently
published in Science, Luco et al. (2010)
have now further extended this coupling,
opening a new chapter in connecting the
histone code to regulated splicing.First noticed by Ahringer and col-
leagues, exons show enrichment of
the histone H3 lysine 36 trimethyl
(H3K36me3) mark relative to introns in
the genome of the nematode Caenorhab-
ditis elegans (Kolasinska-Zwierz et al.,
2009). Several groups quickly realized,
through reanalyzing published nucleo-
some mapping results (particularly from
Figure 1. A Potential Model for Chromatin Influence on Alternative Splicing of the FGFR2
Gene
In human mesenchymal cells (hMSCs), the H3K36me3 mark recruits MGR15, which attracts PTB
binding at intronic splicing silencer elements near exon IIIb, resulting in IIIb exclusion. Attenuation
of this cascade of events by depletion of a H3K36 methyltransferase or MGR15 may derepress IIIb,
allowing it to interfere or compete with IIIc inclusion. In epithelial cells, tissue-specific splicing regulators
such as ESRPs act to promote IIIb inclusion. Overexpression of the H3K36 methyltransferase
or MRG15 may enhance PTB binding, which antagonizes the effect of ESRPs and results in IIIb
suppression.
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Previewshuman T cells), that nucleosomes are
depleted in the intron adjacent to the
acceptor splice site and enriched within
the exons, which appears to largely
account for enriched H3K36me3 marks
on exons (Andersson et al., 2009; Tilgner
et al., 2009; Schwartz et al., 2009). Simi-
larly, strong nucleosome depletion was
also observed at the polyA site, followed
by enrichment immediately downstream
of the polyA site (Spies et al., 2009).
Nucleosome position appears to be
a transcription-independent chromatin
feature because a similar pattern was
observed on both actively and poorly
transcribed genes, despite the fact that
H3K36me3 has previously been linked
to transcriptional elongation. While both
nucleosome affinity and the level of
H3K36me3 are established prior to tran-
scription, highly expressed genes appear
to exhibit reduced nucleosomes on exons
compared with poorly expressed genes,
and the converse is also true for the
H3K36 mark (Schwartz et al., 2009), sug-
gesting that they may still be subjected
to modulation during transcription.The ability for the spliceosome to
recognize splice sites in the vast abyss
of nucleotide sequence has always been
something of a conundrum. Now, it
seems that nucleosome depletion and
enrichment may help delineate where
the intron-exon junction lies and facilitate
exon definition. Remarkably, the length
of a single turn of DNA around the nucleo-
some is the same average length of a
typical human exon preferred by the spli-
ceosome, suggesting an evolutionary
conserved preference for nucleosomes
to reside in exonic regions.
Nucleosome enrichment is clearly rele-
vant to regulated splicing and is inversely
correlated with the strength of splice sites
(Tilgner et al., 2009; Spies et al., 2009).
This has led to a proposal that nucleo-
somes may serve as ‘‘speed bumps’’ to
elongating RNA polymerase II (Schwartz
et al., 2009), similar to a proposed kinetic
model suggesting that a reduced tran-
scriptional elongation rate may afford
increased time for the recognition of
weak splice sites by the splicing machin-
ery during cotranscriptional RNA splicingDevelopmental Cell 1(Kornblihtt, 2007). Alternatively or in addi-
tion, various histone marks may facilitate
the recruitment of splicing regulators to
recognize cis-acting regulatory elements
on emerging nascent RNA to dictate
splice-site selection. A number of studies
now provide evidence for this extended
histone code hypothesis, including a
report showing a role for the H3K4me3
binding protein CHD in binding and re-
cruiting U2 snRNP to facilitate efficient
splicing (Sims et al., 2007), and most
recently, the demonstration of regulated
splicing by the H3K36me3 binding protein
MRG15 (Luco et al., 2010).
In this pivotal study, Luco et al. (2010)
surveyed a number of histone modifica-
tion events on the model human FGFR2
gene, which undergoes tissue-specific
alternative splicing wherein the alterna-
tive exons IIIb or IIIc are selectively
included in cells of epithelial and mesen-
chymal lineages, respectively (Figure 1).
Elegant studies have revealed that the
polypyrimidine tract binding protein PTB
serves as a major suppressor of IIIb in
mesenchymal cells, whereas several
epithelial-specific RNA binding proteins
(ESRPs) function as suppressors of IIIc
in epithelial cells (Warzecha et al., 2009,
and references therein). The selective
effect of PTB on IIIb in mesenchyme is
not well understood because PTB is
abundantly expressed in both mesen-
chymal and epithelial cells. Luco et al.
(2010) now connected an enrichment of
the H3K36me3 mark to the action of
PTB in suppressing the IIIb choice in
human mesenchymal stem cells (hMSCs)
(Luco et al., 2010).
Among the common histone marks
they examined, Luco et al. (2010) focused
on H3K36me3 and found that its binding
protein, MRG15, is able to directly or indi-
rectly interact with PTB to recruit this
splicing repressor to the vicinity of exon
IIIb, but not exon IIIc. Indeed, overexpres-
sion of MRG15 or a methyltransferase for
H3K36me3 enhanced PTB recruitment,
resulting in reduced IIIb inclusion in
FGFR2 splicing in epithelial PNT2 cells.
Because IIIb is already fully suppressed
in hMSCs, further overexpression of
MRG15 or the methyltransferase had little
effect. Conversely, downregulation of
these factors had no effect on IIIb inclu-
sion in PNT2 cells (likely because of the
dominant effect of epithelial-specific
factors such as ESRPs), but caused8, March 16, 2010 ª2010 Elsevier Inc. 337
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Previewsderepressed IIIb to interfere with IIIc inclu-
sion in hMSCs. Luco et al. (2010) next
extended the analysis genome-wide,
showing that a significant portion of
splicing events regulated by PTB were
also regulated by MRG15. The authors
found that the splicing events regulated
by both PTB and MRG15 were similarly
affected in response to RNAi against
PTB or MRG15. A complete overlap
between PTB and MRG15 targets is not
expected because many PTB-dependent
events may not need additional modula-
tion by MRG15, whereas other MRG15-
dependent events might be coupled with
different splicing regulators. These ques-
tions can now be further pursued by
comparing genome-wide MRG15 bind-
ing with the recent genome-wide map
of PTB binding on RNA (Xue et al.,
2009). Interestingly, H3K4me3 distribu-
tion across genes exhibits an opposite
profile to H3K36me3 between PNT2 and
hMSCs, and overexpression of a methyl-
transferase for H3K4me3 reduced IIIc
inclusion by a mechanism that remains
elusive. Furthermore, H3K9me1, a histone
mark generally linked to gene repression,
is selectively enriched on IIIb in PNT2 cells338 Developmental Cell 18, March 16, 2010 ªrelative to hMSCs, raising the possibility
that RNA polymerase II pauses at IIIb to
favor its selection in epithelial cells. These
observations leave open a long list of
questions to be pursued in future studies.
Collectively, the findings of Luco et al.
(2010) demonstrate a clear link between
chromatin features and regulated splic-
ing. We may be looking at just the tip of
the chromatin modification iceberg, con-
sidering the potential combinatory influ-
ence of nucleosome positioning on the
kinetic coupling between transcription
and splicing, appearance of specific cis-
acting elements from nascent RNA, and
recruitment of splicing regulators that
may act in a position- and context-depen-
dent manner. Clearly, complete elucida-
tion of the splicing code must now
consider the contribution of the histone
code. Indeed, it has been reported that
there is increased accuracy in the predic-
tion of splice site usage when information
about nucleosome enrichment is added
to exon prediction programs (Spies
et al., 2009). However, the increase was
relatively small, suggesting a long journey
ahead of us in predicting the splicing
code.2010 Elsevier Inc.REFERENCES
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In this issue of Developmental Cell, Sakano et al. describe a novel mechanism of how a key lymphocyte tran-
scription factor crosstalks to Notch signaling during embryonic development and thereby selectively inhibits
Notch-activated target genes to allow proper left-right patterning.The Notch signaling pathway is recur-
rently used during development in many
cell types and tissues to regulate pro-
cesses such as differentiation, prolifera-
tion, and survival. The signaling cascade
appears to be very simple: binding of
extracellular ligands to Notch receptors
on neighboring cells induces the proteo-lytic cleavage and release of the Notch
intracellular domain (NICD). NICD translo-
cates to the nucleus, heterodimerizes
with the transcription factor CSL (CBF-1
for humans, Suppressor of hairless for
Drosophila, and LAG-1 forCaenorhabditis
elegans, also known as RBP-J in the
mouse), and recruits coactivators, includ-ing Mastermind-like proteins, to induce
transcription of target genes (Bray,
2006). A multitude of Notch target genes
have been identified, some of which are
cell type specific, while others are acti-
vated in many cell types and develop-
mental processes. How Notch signaling
activates only selected target genes
